Skip to main content

Low prevalence of invasive adenocarcinoma and occult cancer on esophageal resection for Barrett’s esophagus with high-grade dysplasia: Evidence for conservative management

Due to the variety of therapeutic options that are currently available for patients diagnosed with Barrett’s-related high-grade dysplasia (BE-HGD), the choice of optimal management continues to be a topic of discussion among gastroenterologists, surgeons, oncologists, pathologists, and patients.

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino